This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Express Scripts Profit Rises 21 Percent In 3rd Qtr

The Associated Press

Express Scripts reported a 20 percent boost in profit for the third quarter, but executives for the pharmacy benefit manager cautioned that the company faces a weaker outlook heading into 2013, and its shares plunged in aftermarket trading.

Express said in a statement "the current weak business climate and the unemployment outlook" could restrain performance next year. "Despite near-term headwinds and a challenging macroeconomic environment, we remain confident we are well-positioned for continued growth," said Express CEO George Paz.

Pharmacy benefits managers, or PBMs, run prescription drug plans for employers, insurers and other customers. They process mail-order prescriptions and handle bills for prescriptions filled at retail pharmacies.

Company shares dropped $9.15, or 14.6 percent, to $53.73 in late trading.

The company closed its $29.1 billion acquisition of Medco, a fellow pharmacy benefits manager, or PBM, in early April. The deal created a company big enough to handle the prescriptions of more than one in three Americans.

The acquisition affected Express Scripts' results across the board, increasing revenue by 133 percent to $26.9 billion. Adjusted prescriptions increased 116 percent to 399 million. The measure counts 90-day mail order prescriptions as three one-month prescriptions.

The company reported net income of $391 million, or 47 cents per share in the three months that ended September 30. That compares to earnings of $324.7 million, or 66 cents per share, in last year's quarter. The company's outstanding shares ballooned after the Medco acquisition, pushing down per-share results.

Excluding the impact of the transaction, the company would have earned $1.02 per share in the quarter.

Analysts expected earnings of 99 cents per share on $27.5 billion in revenue, according to FactSet.

The company raised the lower range of its earnings guidance, predicting 2012 results between $3.65 and $3.75. Wall Street expects, on average, profit of $3.71 per share, with estimates ranging from $3.61 to $3.80.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs